Market Executive Summary
This report aims to provide a comprehensive presentation of the global market for Hepatic Encephalopathy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatic Encephalopathy Treatment.
The Hepatic Encephalopathy Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hepatic Encephalopathy Treatment market comprehensively. Regional market sizes, concerning products by route, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatic Encephalopathy Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by route, by application and by regions.
By Company
Mallinckrodt Pharmaceuticals
Salix Pharmaceuticals
GlaxoSmithKline plc.
Pfizer Inc.
ASKA Pharmaceutical Co., Ltd.
Bausch Health
Johnson & Johnson Services, Inc.
Janssen Global Services
Takeda Pharmaceutical Company Limited
Merck & Co., Inc.
Segment by Route
Oral
Injectable
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatic Encephalopathy Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatic Encephalopathy Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by route, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Hepatic Encephalopathy Treatment Market Overview
1.1 Product Overview and Scope of Hepatic Encephalopathy Treatment
1.2 Hepatic Encephalopathy Treatment Segment by Route
1.2.1 Global Hepatic Encephalopathy Treatment Market Value Comparison by Route (2023-2029)
1.2.2 Oral
1.2.3 Injectable
1.3 Hepatic Encephalopathy Treatment Segment by Application
1.3.1 Global Hepatic Encephalopathy Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Hepatic Encephalopathy Treatment Market Size Estimates and Forecasts
1.4.1 Global Hepatic Encephalopathy Treatment Revenue 2018-2029
1.4.2 Global Hepatic Encephalopathy Treatment Sales 2018-2029
1.4.3 Global Hepatic Encephalopathy Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hepatic Encephalopathy Treatment Market Competition by Manufacturers
2.1 Global Hepatic Encephalopathy Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hepatic Encephalopathy Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hepatic Encephalopathy Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Hepatic Encephalopathy Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatic Encephalopathy Treatment, Product Type & Application
2.7 Hepatic Encephalopathy Treatment Market Competitive Situation and Trends
2.7.1 Hepatic Encephalopathy Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatic Encephalopathy Treatment Players Market Share by Revenue
2.7.3 Global Hepatic Encephalopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatic Encephalopathy Treatment Retrospective Market Scenario by Region
3.1 Global Hepatic Encephalopathy Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hepatic Encephalopathy Treatment Global Hepatic Encephalopathy Treatment Sales by Region: 2018-2029
3.2.1 Global Hepatic Encephalopathy Treatment Sales by Region: 2018-2023
3.2.2 Global Hepatic Encephalopathy Treatment Sales by Region: 2024-2029
3.3 Global Hepatic Encephalopathy Treatment Global Hepatic Encephalopathy Treatment Revenue by Region: 2018-2029
3.3.1 Global Hepatic Encephalopathy Treatment Revenue by Region: 2018-2023
3.3.2 Global Hepatic Encephalopathy Treatment Revenue by Region: 2024-2029
3.4 North America Hepatic Encephalopathy Treatment Market Facts & Figures by Country
3.4.1 North America Hepatic Encephalopathy Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hepatic Encephalopathy Treatment Sales by Country (2018-2029)
3.4.3 North America Hepatic Encephalopathy Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatic Encephalopathy Treatment Market Facts & Figures by Country
3.5.1 Europe Hepatic Encephalopathy Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hepatic Encephalopathy Treatment Sales by Country (2018-2029)
3.5.3 Europe Hepatic Encephalopathy Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatic Encephalopathy Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatic Encephalopathy Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hepatic Encephalopathy Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Hepatic Encephalopathy Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hepatic Encephalopathy Treatment Market Facts & Figures by Country
3.7.1 Latin America Hepatic Encephalopathy Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hepatic Encephalopathy Treatment Sales by Country (2018-2029)
3.7.3 Latin America Hepatic Encephalopathy Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hepatic Encephalopathy Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatic Encephalopathy Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hepatic Encephalopathy Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hepatic Encephalopathy Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Route
4.1 Global Hepatic Encephalopathy Treatment Sales by Route (2018-2029)
4.1.1 Global Hepatic Encephalopathy Treatment Sales by Route (2018-2023)
4.1.2 Global Hepatic Encephalopathy Treatment Sales by Route (2024-2029)
4.1.3 Global Hepatic Encephalopathy Treatment Sales Market Share by Route (2018-2029)
4.2 Global Hepatic Encephalopathy Treatment Revenue by Route (2018-2029)
4.2.1 Global Hepatic Encephalopathy Treatment Revenue by Route (2018-2023)
4.2.2 Global Hepatic Encephalopathy Treatment Revenue by Route (2024-2029)
4.2.3 Global Hepatic Encephalopathy Treatment Revenue Market Share by Route (2018-2029)
4.3 Global Hepatic Encephalopathy Treatment Price by Route (2018-2029)
5 Segment by Application
5.1 Global Hepatic Encephalopathy Treatment Sales by Application (2018-2029)
5.1.1 Global Hepatic Encephalopathy Treatment Sales by Application (2018-2023)
5.1.2 Global Hepatic Encephalopathy Treatment Sales by Application (2024-2029)
5.1.3 Global Hepatic Encephalopathy Treatment Sales Market Share by Application (2018-2029)
5.2 Global Hepatic Encephalopathy Treatment Revenue by Application (2018-2029)
5.2.1 Global Hepatic Encephalopathy Treatment Revenue by Application (2018-2023)
5.2.2 Global Hepatic Encephalopathy Treatment Revenue by Application (2024-2029)
5.2.3 Global Hepatic Encephalopathy Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Hepatic Encephalopathy Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Corporation Information
6.1.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.2 Salix Pharmaceuticals
6.2.1 Salix Pharmaceuticals Corporation Information
6.2.2 Salix Pharmaceuticals Description and Business Overview
6.2.3 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product Portfolio
6.2.5 Salix Pharmaceuticals Recent Developments/Updates
6.3 GlaxoSmithKline plc.
6.3.1 GlaxoSmithKline plc. Corporation Information
6.3.2 GlaxoSmithKline plc. Description and Business Overview
6.3.3 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product Portfolio
6.3.5 GlaxoSmithKline plc. Recent Developments/Updates
6.4 Pfizer Inc.
6.4.1 Pfizer Inc. Corporation Information
6.4.2 Pfizer Inc. Description and Business Overview
6.4.3 Pfizer Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc. Hepatic Encephalopathy Treatment Product Portfolio
6.4.5 Pfizer Inc. Recent Developments/Updates
6.5 ASKA Pharmaceutical Co., Ltd.
6.5.1 ASKA Pharmaceutical Co., Ltd. Corporation Information
6.5.2 ASKA Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product Portfolio
6.5.5 ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Bausch Health
6.6.1 Bausch Health Corporation Information
6.6.2 Bausch Health Description and Business Overview
6.6.3 Bausch Health Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bausch Health Hepatic Encephalopathy Treatment Product Portfolio
6.6.5 Bausch Health Recent Developments/Updates
6.7 Johnson & Johnson Services, Inc.
6.6.1 Johnson & Johnson Services, Inc. Corporation Information
6.6.2 Johnson & Johnson Services, Inc. Description and Business Overview
6.6.3 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product Portfolio
6.7.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
6.8 Janssen Global Services
6.8.1 Janssen Global Services Corporation Information
6.8.2 Janssen Global Services Description and Business Overview
6.8.3 Janssen Global Services Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Janssen Global Services Hepatic Encephalopathy Treatment Product Portfolio
6.8.5 Janssen Global Services Recent Developments/Updates
6.9 Takeda Pharmaceutical Company Limited
6.9.1 Takeda Pharmaceutical Company Limited Corporation Information
6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.9.3 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product Portfolio
6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.10 Merck & Co., Inc.
6.10.1 Merck & Co., Inc. Corporation Information
6.10.2 Merck & Co., Inc. Description and Business Overview
6.10.3 Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merck & Co., Inc. Hepatic Encephalopathy Treatment Product Portfolio
6.10.5 Merck & Co., Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatic Encephalopathy Treatment Industry Chain Analysis
7.2 Hepatic Encephalopathy Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatic Encephalopathy Treatment Production Mode & Process
7.4 Hepatic Encephalopathy Treatment Sales and Marketing
7.4.1 Hepatic Encephalopathy Treatment Sales Channels
7.4.2 Hepatic Encephalopathy Treatment Distributors
7.5 Hepatic Encephalopathy Treatment Customers
8 Hepatic Encephalopathy Treatment Market Dynamics
8.1 Hepatic Encephalopathy Treatment Industry Trends
8.2 Hepatic Encephalopathy Treatment Market Drivers
8.3 Hepatic Encephalopathy Treatment Market Challenges
8.4 Hepatic Encephalopathy Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figures
List of Tables
Table 1. Global Hepatic Encephalopathy Treatment Market Value Comparison by Route (2023-2029) & (US$ Million)
Table 2. Global Hepatic Encephalopathy Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Hepatic Encephalopathy Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Hepatic Encephalopathy Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hepatic Encephalopathy Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hepatic Encephalopathy Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hepatic Encephalopathy Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hepatic Encephalopathy Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hepatic Encephalopathy Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Hepatic Encephalopathy Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatic Encephalopathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatic Encephalopathy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Hepatic Encephalopathy Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Hepatic Encephalopathy Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Hepatic Encephalopathy Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Hepatic Encephalopathy Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Hepatic Encephalopathy Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hepatic Encephalopathy Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Hepatic Encephalopathy Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Hepatic Encephalopathy Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Hepatic Encephalopathy Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Hepatic Encephalopathy Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Hepatic Encephalopathy Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Hepatic Encephalopathy Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hepatic Encephalopathy Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Hepatic Encephalopathy Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Hepatic Encephalopathy Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hepatic Encephalopathy Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Hepatic Encephalopathy Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hepatic Encephalopathy Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Hepatic Encephalopathy Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Hepatic Encephalopathy Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hepatic Encephalopathy Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Hepatic Encephalopathy Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hepatic Encephalopathy Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hepatic Encephalopathy Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Hepatic Encephalopathy Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hepatic Encephalopathy Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Hepatic Encephalopathy Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hepatic Encephalopathy Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hepatic Encephalopathy Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Hepatic Encephalopathy Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hepatic Encephalopathy Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Hepatic Encephalopathy Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hepatic Encephalopathy Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Hepatic Encephalopathy Treatment Sales (K Units) by Route (2018-2023)
Table 51. Global Hepatic Encephalopathy Treatment Sales (K Units) by Route (2024-2029)
Table 52. Global Hepatic Encephalopathy Treatment Sales Market Share by Route (2018-2023)
Table 53. Global Hepatic Encephalopathy Treatment Sales Market Share by Route (2024-2029)
Table 54. Global Hepatic Encephalopathy Treatment Revenue (US$ Million) by Route (2018-2023)
Table 55. Global Hepatic Encephalopathy Treatment Revenue (US$ Million) by Route (2024-2029)
Table 56. Global Hepatic Encephalopathy Treatment Revenue Market Share by Route (2018-2023)
Table 57. Global Hepatic Encephalopathy Treatment Revenue Market Share by Route (2024-2029)
Table 58. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Route (2018-2023)
Table 59. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Route (2024-2029)
Table 60. Global Hepatic Encephalopathy Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Hepatic Encephalopathy Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Hepatic Encephalopathy Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Hepatic Encephalopathy Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Hepatic Encephalopathy Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hepatic Encephalopathy Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Hepatic Encephalopathy Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Hepatic Encephalopathy Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Mallinckrodt Pharmaceuticals Corporation Information
Table 71. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 72. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Mallinckrodt Pharmaceuticals Hepatic Encephalopathy Treatment Product
Table 74. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 75. Salix Pharmaceuticals Corporation Information
Table 76. Salix Pharmaceuticals Description and Business Overview
Table 77. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Salix Pharmaceuticals Hepatic Encephalopathy Treatment Product
Table 79. Salix Pharmaceuticals Recent Developments/Updates
Table 80. GlaxoSmithKline plc. Corporation Information
Table 81. GlaxoSmithKline plc. Description and Business Overview
Table 82. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline plc. Hepatic Encephalopathy Treatment Product
Table 84. GlaxoSmithKline plc. Recent Developments/Updates
Table 85. Pfizer Inc. Corporation Information
Table 86. Pfizer Inc. Description and Business Overview
Table 87. Pfizer Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Inc. Hepatic Encephalopathy Treatment Product
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. ASKA Pharmaceutical Co., Ltd. Corporation Information
Table 91. ASKA Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. ASKA Pharmaceutical Co., Ltd. Hepatic Encephalopathy Treatment Product
Table 94. ASKA Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Bausch Health Corporation Information
Table 96. Bausch Health Description and Business Overview
Table 97. Bausch Health Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bausch Health Hepatic Encephalopathy Treatment Product
Table 99. Bausch Health Recent Developments/Updates
Table 100. Johnson & Johnson Services, Inc. Corporation Information
Table 101. Johnson & Johnson Services, Inc. Description and Business Overview
Table 102. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Johnson & Johnson Services, Inc. Hepatic Encephalopathy Treatment Product
Table 104. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 105. Janssen Global Services Corporation Information
Table 106. Janssen Global Services Description and Business Overview
Table 107. Janssen Global Services Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Janssen Global Services Hepatic Encephalopathy Treatment Product
Table 109. Janssen Global Services Recent Developments/Updates
Table 110. Takeda Pharmaceutical Company Limited Corporation Information
Table 111. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 112. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Takeda Pharmaceutical Company Limited Hepatic Encephalopathy Treatment Product
Table 114. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 115. Merck & Co., Inc. Corporation Information
Table 116. Merck & Co., Inc. Description and Business Overview
Table 117. Merck & Co., Inc. Hepatic Encephalopathy Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Merck & Co., Inc. Hepatic Encephalopathy Treatment Product
Table 119. Merck & Co., Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Hepatic Encephalopathy Treatment Distributors List
Table 123. Hepatic Encephalopathy Treatment Customers List
Table 124. Hepatic Encephalopathy Treatment Market Trends
Table 125. Hepatic Encephalopathy Treatment Market Drivers
Table 126. Hepatic Encephalopathy Treatment Market Challenges
Table 127. Hepatic Encephalopathy Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatic Encephalopathy Treatment
Figure 2. Global Hepatic Encephalopathy Treatment Market Value Comparison by Route (2023-2029) & (US$ Million)
Figure 3. Global Hepatic Encephalopathy Treatment Market Share by Route in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Injectable Product Picture
Figure 6. Global Hepatic Encephalopathy Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Hepatic Encephalopathy Treatment Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Hepatic Encephalopathy Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hepatic Encephalopathy Treatment Market Size (2018-2029) & (US$ Million)
Figure 13. Global Hepatic Encephalopathy Treatment Sales (2018-2029) & (K Units)
Figure 14. Global Hepatic Encephalopathy Treatment Average Price (US$/Unit) & (2018-2029)
Figure 15. Hepatic Encephalopathy Treatment Report Years Considered
Figure 16. Hepatic Encephalopathy Treatment Sales Share by Manufacturers in 2022
Figure 17. Global Hepatic Encephalopathy Treatment Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Hepatic Encephalopathy Treatment Players: Market Share by Revenue in 2022
Figure 19. Hepatic Encephalopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Hepatic Encephalopathy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Hepatic Encephalopathy Treatment Sales Market Share by Country (2018-2029)
Figure 22. North America Hepatic Encephalopathy Treatment Revenue Market Share by Country (2018-2029)
Figure 23. United States Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Hepatic Encephalopathy Treatment Sales Market Share by Country (2018-2029)
Figure 26. Europe Hepatic Encephalopathy Treatment Revenue Market Share by Country (2018-2029)
Figure 27. Germany Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Hepatic Encephalopathy Treatment Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Hepatic Encephalopathy Treatment Revenue Market Share by Region (2018-2029)
Figure 34. China Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Hepatic Encephalopathy Treatment Sales Market Share by Country (2018-2029)
Figure 42. Latin America Hepatic Encephalopathy Treatment Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hepatic Encephalopathy Treatment Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Hepatic Encephalopathy Treatment Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Hepatic Encephalopathy Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Hepatic Encephalopathy Treatment by Route (2018-2029)
Figure 53. Global Revenue Market Share of Hepatic Encephalopathy Treatment by Route (2018-2029)
Figure 54. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Route (2018-2029)
Figure 55. Global Sales Market Share of Hepatic Encephalopathy Treatment by Application (2018-2029)
Figure 56. Global Revenue Market Share of Hepatic Encephalopathy Treatment by Application (2018-2029)
Figure 57. Global Hepatic Encephalopathy Treatment Price (US$/Unit) by Application (2018-2029)
Figure 58. Hepatic Encephalopathy Treatment Value Chain
Figure 59. Hepatic Encephalopathy Treatment Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
